Compare · COR vs MEDS
COR vs MEDS
Side-by-side comparison of Cencora Inc. (COR) and TRxADE HEALTH Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $63.15B, about 21561.5x MEDS ($2.9M).
- Over the past year, COR is up 11.1% and MEDS is down 98.8% - COR leads by 109.9 points.
- Both names hit the wire about 3 times in the past 4 weeks.
- COR has more recent analyst coverage (25 ratings vs 1 for MEDS).
- Company
- Cencora Inc.
- TRxADE HEALTH Inc.
- Price
- $331.00-1.79%
- $0.96-4.94%
- Market cap
- $63.15B
- $2.9M
- 1M return
- +1.72%
- -67.01%
- 1Y return
- +11.13%
- -98.78%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 3
- Recent ratings
- 25
- 1
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
TRxADE HEALTH Inc.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Latest COR
- SVP & Chief Accounting Officer Krikorian Lazarus sold $321,080 worth of shares (985 units at $325.97) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 16,169 units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S sold $3,662,663 worth of shares (11,300 units at $324.12), decreasing direct ownership by 37% to 19,455 units (SEC Form 4)
- RBC Capital Mkts initiated coverage on Cencora with a new price target
- Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form 10-Q filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Reports Fiscal 2026 Third Quarter Results
- Director Nally Dennis M was granted 113 shares, increasing direct ownership by 0.86% to 13,188 units (SEC Form 4)
- Director Cooper Ellen was granted 97 shares, increasing direct ownership by 12% to 893 units (SEC Form 4)
Latest MEDS
- CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
- DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
- DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
- DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026
- DataMeds AI Provides Update on Corexa Health's Pharmacy Division
- DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
- DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
- DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
- DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
- DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License